Rehabilitation counseling for patients with interstitial lung disease
Rehabilitation Counselling for Patients with Interstitial Lung Disease
This study is trying to see if rehabilitation counseling can help improve the physical and emotional well-being of patients with idiopathic pulmonary fibrosis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna, Bologna) |
| Trial ID | NCT06815185 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that leads to progressive loss of lung function. It aims to observe the effects of rehabilitation counseling provided to patients attending the IPF clinic at the IRCCS Company Bologna University Hospital. The study utilizes a multidisciplinary approach as part of a diagnostic therapeutic care path for pulmonary fibrosis, assessing how rehabilitation can improve physical and emotional well-being in these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with idiopathic pulmonary fibrosis who can provide informed consent.
Not a fit: Patients with active cancer or those experiencing clinical instability that prevents them from attending follow-up visits may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life and emotional well-being of patients suffering from interstitial lung disease.
How similar studies have performed: While this approach is part of a broader multidisciplinary strategy, the specific effects of rehabilitation counseling in IPF patients have not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age\>/= 18 years old; * Obtaining the patient\'s informed consent Exclusion Criteria: * Diagnosis of active cancer * Situations of clinical instability, clinical aggravation such as to consider unsuitable the individual to treatment because he or she is no longer able to go to follow-up visits
Where this trial is running
Bologna, Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (Recruiting)
Study contacts
- Principal investigator: Enrica Cavalli, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Enrica Cavalli, MD
- Email: enrica.cavalli@aosp.bo.it
- Phone: 0512142285
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.